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At its simplest, we can express body weight or body com-
position as comprising of adipose tissue, muscle tissue and
skeletal tissue. Body weight and body mass index (BMI) of
populations of all ages have been increasing for close to half
a century, leading to the present obesity epidemic. The
causal pathways linking excessive body fat to serious chron-
ic diseases, including diabetes and heart diseases is now
well established.
A recent editorial citing body composition data from Li et
al. [1] asked the question “Are Normal-Weight Americans
Over-Fat?” [2]. This interpretation of the data from Li et al.
reinforces an adipocentric view giving adipose tissue prima-
cy; perhaps there is a different view, a sarcocentric view that
proposes that people are perhaps becoming under-muscled
rather than just over-fat. Data from Canada [3] and Germany
[4] indicate that children and adults are getting fatter at the
same body weight or BMI. If we are fatter at the same body
weight and BMI then the other two tissues, muscle and or
bone must be diminishing. Given that this increased body
fatness atthe sameweightismostlikelya proxy for decreased
physical activity, it is a good bet that muscle is the tissue that
has diminished most. The loss of muscle is of great physio-
logical importance as proper-functioning muscle is responsi-
ble for most glucose disposal and required to stave off insulin
resistance [5, 6]. Proper functioning muscle has been high-
lighted as important for longevity even after accounting for
respiratory fitness and BMI [7].
Therefore it is important to remind those with an adipo-
centric perspective that a low body fat in itself is not neces-
sarily healthy if it coexists with poor-quality muscle and
bone. This is important given various body composition
states such as metabolically normal obese individuals [8]
and thin persons with significant ectopic fat [9]. We may
have better health outcomes if we focus more on the causes
and sequelae of body dyscomposition, especially the dimi-
nution of muscle mass and function even in the young,
rather than assuming the problems of body composition in
the general population largely lie in terms of adiposity.
The retention and maintenance of muscle and muscle
function is coming under increasing scrutiny in our ageing
society because of the looming epidemic of sarcopenia and
the financial and social impact that this will have. However,
the discussion around the diagnosis and prevalence on sar-
copenia is centred on the target clinical population, i.e., the
elderly [10]. Nevertheless, the data cited above from the
USA, Canada and Germany studies highlight that on current
form, a number of our children may not meet their genetic
potential of muscle mass and by inference muscle function.
The medium-term consequences of this muscle shortfall as a
risk factor for type 2 diabetes alone is of concern; the
longer-term consequences of any muscle shortfall to sarco-
penia prevalence and its possible inception at a younger age
should be of even greater concern. Those concerned with
sarcopenia, including this journal, perhaps need also to
focus more on prevention even starting with childhood.
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